In: European Spine Journal, 2015, vol. 24, p. 540-543
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1755-1758
|
In: Journal of Infectious Diseases, ///-
|
In: Journal of Antimicrobial Chemotherapy, 2017, vol. 72, no. 9, p. 2574-2577
|
In: Pflügers Archiv - European Journal of Physiology, 2015, vol. 467, no. 7, p. 1481-1493
|
In: Journal of Infectious Diseases, ///-
|
In: Cerebral Cortex, 2018, vol. 28, no. 1, p. 184-198
|
In: Journal of Antimicrobial Chemotherapy, 2018, vol. 73, no. 10, p. 2729-2737
|
In: Journal of Antimicrobial Chemotherapy, 2016, vol. 71, no. 7, p. 1933-1942
|
In: Plos one, 2012, vol. 7, no. 4, p. e35485
Based on the partial efficacy of the HIV/AIDS Thai trial (RV144) with a canarypox vector prime and protein boost, attenuated poxvirus recombinants expressing HIV-1 antigens are increasingly sought as vaccine candidates against HIV/AIDS. Here we describe using systems analysis the biological and immunological characteristics of the attenuated vaccinia virus Ankara strain expressing the HIV-1...
|